NO20070354L - Galeniske anvendelser om selvemulgerende blandinger av lipideksipienter - Google Patents

Galeniske anvendelser om selvemulgerende blandinger av lipideksipienter

Info

Publication number
NO20070354L
NO20070354L NO20070354A NO20070354A NO20070354L NO 20070354 L NO20070354 L NO 20070354L NO 20070354 A NO20070354 A NO 20070354A NO 20070354 A NO20070354 A NO 20070354A NO 20070354 L NO20070354 L NO 20070354L
Authority
NO
Norway
Prior art keywords
self
lipid excipients
emulsifying mixtures
galenic
applications
Prior art date
Application number
NO20070354A
Other languages
English (en)
Norwegian (no)
Inventor
Jean Pachot
Serge Segot Chicq
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20070354L publication Critical patent/NO20070354L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20070354A 2004-07-27 2007-01-19 Galeniske anvendelser om selvemulgerende blandinger av lipideksipienter NO20070354L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0408269A FR2873585B1 (fr) 2004-07-27 2004-07-27 Nouvelles formulations galeniques de principes actifs
PCT/FR2005/001853 WO2006018501A1 (fr) 2004-07-27 2005-07-20 Applications galeniques de melanges auto-emulsionnants d'excipients lipidiques

Publications (1)

Publication Number Publication Date
NO20070354L true NO20070354L (no) 2007-04-17

Family

ID=34951660

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070354A NO20070354L (no) 2004-07-27 2007-01-19 Galeniske anvendelser om selvemulgerende blandinger av lipideksipienter

Country Status (18)

Country Link
US (2) US20080193519A1 (pt)
EP (1) EP1771154A1 (pt)
JP (1) JP2008508191A (pt)
KR (1) KR20070046819A (pt)
CN (1) CN101001608A (pt)
AU (1) AU2005273839A1 (pt)
BR (1) BRPI0513622A (pt)
CA (1) CA2579449A1 (pt)
FR (1) FR2873585B1 (pt)
IL (1) IL180714A0 (pt)
MA (1) MA28748B1 (pt)
MX (1) MX2007001141A (pt)
NO (1) NO20070354L (pt)
NZ (1) NZ552715A (pt)
RU (1) RU2381789C2 (pt)
TW (1) TW200616640A (pt)
WO (1) WO2006018501A1 (pt)
ZA (1) ZA200700553B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1867323A1 (en) * 2006-06-13 2007-12-19 Farmatron Ltd. Pharmaceutical compositions with biological barriers permeation enhancing properties
AU2008290536B2 (en) * 2007-08-21 2012-02-09 Basilea Pharmaceutica Ag Antifungal composition
WO2011047259A1 (en) 2009-10-16 2011-04-21 Glaxosmithkline Llc Compositions
JP2013209294A (ja) * 2010-07-30 2013-10-10 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 液状医薬組成物
LT2782584T (lt) 2011-11-23 2021-09-10 Therapeuticsmd, Inc. Natūralios kombinuotos pakaitinės hormonų terapijos kompozicijos ir gydymas
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
KR101542364B1 (ko) * 2014-10-31 2015-08-07 대화제약 주식회사 탁산을 포함하는 경구 투여용 약학 조성물
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
KR20210102936A (ko) * 2018-12-10 2021-08-20 헤일로 사이언스 엘엘씨 안정적인 마취제 제제 및 관련 복용량 형태
CZ309587B6 (cs) * 2021-01-22 2023-05-03 Oncora S.R.O. Mikroemulzní prekoncentrát s obsahem kladribinu a způsob jeho přípravy
CN114246827B (zh) * 2022-01-04 2023-04-11 中山大学 一种鱼油微乳制剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8916901D0 (en) * 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US6054136A (en) * 1993-09-30 2000-04-25 Gattefosse S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
FR2710535B1 (fr) * 1993-09-30 1995-11-24 Gattefosse Ets Sa Composition à usage pharmaceutique ou cosmétique apte à former une microémulsion.
EP0933367A1 (en) * 1997-12-19 1999-08-04 Hoechst Marion Roussel Deutschland GmbH Novel acylguanidine derivates as inhibitors of bone resorption and as vitronectin receptor antagonists
SK10632000A3 (sk) * 1998-01-23 2001-02-12 Aventis Pharma Deutschland Gmbh Sulfónamidové deriváty ako inhibítory resorpcie kostí a inhibítory bunkovej adhézie
ATE327735T1 (de) * 1998-04-01 2006-06-15 Jagotec Ag Taxan-mikroemulsionen
WO2000003753A2 (en) * 1998-07-14 2000-01-27 Em Industries, Inc. Microdisperse drug delivery systems
GB0003685D0 (en) * 2000-02-17 2000-04-05 Univ Cardiff Sensitisation of cellular material
FR2818905A1 (fr) * 2000-12-28 2002-07-05 Cll Pharma Compositions pharmaceutiques colloidales micellaires renfermant un principe actif lipophile
FR2827770B1 (fr) * 2001-07-27 2005-08-19 Gattefosse Ets Sa Composition pharmaceutique a usage oral comprenant un principe actif susceptible de subir un important effet de premier passage intestinal
US20040092428A1 (en) * 2001-11-27 2004-05-13 Hongming Chen Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof
WO2003095447A1 (en) * 2002-05-14 2003-11-20 Xenova Limited Process for the preparation of a hydrate of an anthranilic acid derivative

Also Published As

Publication number Publication date
MA28748B1 (fr) 2007-07-02
US20110104268A1 (en) 2011-05-05
WO2006018501A8 (fr) 2007-03-01
KR20070046819A (ko) 2007-05-03
CA2579449A1 (en) 2006-02-23
FR2873585A1 (fr) 2006-02-03
TW200616640A (en) 2006-06-01
ZA200700553B (en) 2008-05-28
IL180714A0 (en) 2007-06-03
BRPI0513622A (pt) 2008-05-13
US20080193519A1 (en) 2008-08-14
AU2005273839A1 (en) 2006-02-23
MX2007001141A (es) 2007-04-19
NZ552715A (en) 2010-12-24
RU2381789C2 (ru) 2010-02-20
CN101001608A (zh) 2007-07-18
FR2873585B1 (fr) 2006-11-17
EP1771154A1 (fr) 2007-04-11
RU2007107199A (ru) 2008-09-10
WO2006018501A1 (fr) 2006-02-23
JP2008508191A (ja) 2008-03-21

Similar Documents

Publication Publication Date Title
NO20070354L (no) Galeniske anvendelser om selvemulgerende blandinger av lipideksipienter
NO20064584L (no) Tetrahydropyridoindolderivater
NO20071354L (no) anvendelse av samme Butylftalid selvemulsifiserene medikamentavgivelsessystem, samt fremgangsmater for fremstilling og anvendelse av samme.
NO20073059L (no) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
NO20064347L (no) Substituerte 1,2,3,4-tetrahydroisokinolinderivater
NO20082269L (no) Nye piperaziner som antimalariamidler
NO20076648L (no) Novel thiophene derivatives
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
MX2010004549A (es) Composiciones y métodos bacteriostáticos o bactericidas.
NO20060981L (no) Pyridazinderivater og deres anvendelse som terapeutiske midler
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
NO20080284L (no) Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer
AR067184A1 (es) Uso de 6-(3-cloro-2-fluorbencil)-1-[(2s)-1-hidroxi-3-metilbutan-2-il]-7-metoxi-4-oxo-1,4-dihidroquinolina-3-carboxilico. composicion farmaceutica
NO20055977L (no) Nye benzimidazolderivater
NO20081628L (no) Benzodiazepiner som HCV-inhibitorer
NO20062923L (no) Nye benzofuranderivater som kan anvendes i forebygging eller behandling av 5-HT6 reseptorrelatert forstyrrelse
AR044050A1 (es) Utilizacion de ivermectina para el tratamiento de desordenes dermatologicos
NO20072051L (no) Nye pyrimidinderivater og deres anvendelse som PPAR-alfa modulatorar
EA201001288A1 (ru) Лечение гипертонии 25-гидроксивитамином d3
DK2046292T3 (da) Formuleringer for benzimidazolylpyridylethere
DK1341524T3 (da) Farmaceutisk præparat i form af en pasta omfattende en syre-labil aktiv bestanddel
DK1469843T3 (da) Komposition til farmaceutisk eller diætetisk anvendelse til at bekæmpe hårtab
DE50203456D1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
ECSP067074A (es) Derivados de 4-fenil-pirimidina-2-carbonitrilo
MEP20908A (en) Thienopyrazoles

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA

FC2A Withdrawal, rejection or dismissal of laid open patent application